VEGFA and type 1 diabetes mellitus: Although the subgroup analysis failed to explain the source of the heterogeneity, we were surprised to find that the increase in VEGF was no longer significant when the study population included type 1 diabetes regardless of the subjects with which DPN patients were compared (healthy people or diabetic people without DPN).